Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Management Tracks

Biondi becomes managing partner at Flagship

Plus: New CMOs at Epitopea and Cadrenal

February 7, 2025 11:28 PM UTC

Paul Biondi has become a managing partner at Flagship Pioneering Inc., which he joined in 2019 as executive partner to start Pioneering Medicines, an internal drug development group created to advance promising but deprioritized assets from across Flagship's platform companies. Biondi became a general partner at the firm last year.

Epitopea Ltd., which is developing RNA-based immunotherapies to treat cancer, hired Klaus Edvardsen as CMO. Edvardsen was chief development officer of Nykode Therapeutics ASA (OSE:NYKD)...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article